PharmaEssentia (FRA:8Z1) Cyclically Adjusted Book per Share: €0.00 (As of Dec. 2025)


FRA:8Z1 PharmaEssentia Corp FRA:8Z1
82 GF Score
Price €15.50
GF Value €14.50
! 6 Warning Signs
View Full Analysis

What is PharmaEssentia Cyclically Adjusted Book per Share?

PharmaEssentia FRA:8Z1 82 Cyclically Adjusted Book per Share is €0.00 as of Dec. 2025. GuruFocus rates FRA:8Z1 with a GF Score™ of 82/100 and a GF Value™ of €14.50. The stock has 6 warning signs investors should review.

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PharmaEssentia's adjusted book value per share for the three months ended in Dec. 2025 was €2.347. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Dec. 2025.

During the past 12 months, PharmaEssentia's average Cyclically Adjusted Book Growth Rate was 28.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-07), PharmaEssentia's current stock price is €15.50. PharmaEssentia's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was €0.00. PharmaEssentia's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaEssentia was 44.14. The lowest was 12.50. And the median was 19.60.


PharmaEssentia  (FRA:8Z1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaEssentia was 44.14. The lowest was 12.50. And the median was 19.60.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PharmaEssentia Cyclically Adjusted Book per Share Related Terms


PharmaEssentia Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia Cyclically Adjusted Book per Share Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PharmaEssentia Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:8Z1 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEssentia Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's Cyclically Adjusted PB Ratio falls into.


FRA:8Z1
82GF Score
PharmaEssentia Corp FRA:8Z1
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaEssentia's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=2.347/324.0540*324.0540
=2.347

Current CPI (Dec. 2025) = 324.0540.

PharmaEssentia Quarterly Data

Book Value per Share CPI Adj_Book
201603 0.159 238.132 0.216
201606 0.154 241.018 0.207
201609 0.509 241.428 0.683
201612 0.507 241.432 0.681
201703 0.501 243.801 0.666
201706 0.457 244.955 0.605
201709 0.412 246.819 0.541
201712 0.391 246.524 0.514
201803 0.362 249.554 0.470
201806 0.346 251.989 0.445
201809 0.314 252.439 0.403
201812 0.282 251.233 0.364
201903 0.256 254.202 0.326
201906 0.234 256.143 0.296
201909 0.214 256.759 0.270
201912 0.261 256.974 0.329
202003 0.233 258.115 0.293
202006 0.364 257.797 0.458
202009 0.491 260.280 0.611
202012 0.390 260.474 0.485
202103 0.321 264.877 0.393
202106 0.268 271.696 0.320
202109 0.203 274.310 0.240
202112 0.442 278.802 0.514
202203 0.413 287.504 0.466
202206 0.562 296.311 0.615
202209 0.554 296.808 0.605
202212 1.117 296.797 1.220
202303 1.100 301.836 1.181
202306 2.023 305.109 2.149
202309 1.899 307.789 1.999
202312 1.911 306.746 2.019
202403 1.924 312.332 1.996
202406 1.972 314.175 2.034
202409 1.994 315.301 2.049
202412 2.250 315.605 2.310
202503 2.210 319.799 2.239
202506 2.259 322.561 2.269
202509 2.257 324.800 2.252
202512 2.347 324.054 2.347

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.00 mean?
PharmaEssentia (FRA:8Z1) has a Cyclically Adjusted Book per Share of €0.00 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's Cyclically Adjusted Book per Share too high?
PharmaEssentia's current Cyclically Adjusted Book per Share is €0.00. Overall, PharmaEssentia has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
PharmaEssentia's Cyclically Adjusted Book per Share of €0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current Cyclically Adjusted Book per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
PharmaEssentia (FRA:8Z1) has a current Cyclically Adjusted Book per Share of €0.00. The stock's GF Value™ is €14.50, compared to a current price of €15.50 — trading 6.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is €0.00. PharmaEssentia's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PharmaEssentia (FRA:8Z1), the current Cyclically Adjusted Book per Share is €0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (FRA:8Z1) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of €15.50 is trading 6.9% above its estimated GF Value™ of €14.50.

Key valuation signals for FRA:8Z1:

  • Cyclically Adjusted Book per Share: €0.00
  • GF Value™: €14.50 vs. price of €15.50 (6.9% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the FRA:8Z1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaEssentia Business Description

Other Exchanges 6446:Taiwan
Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
82GF Score

Get the complete analysis for FRA:8Z1

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.50
Price
€14.50
GF Value